XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.2%

Dec 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16049)	9/9/2002 9:34:19 AM
From: aknahow	Read Replies (2) of 17367

O.K. so. He was hopeful then, but two years have gone by. Is he hopeful now? ""Despite the positive findings and the fact that meningococcemia has been declared an orphan disease, the Food and Drug Administration declined earlier this year to grant approval of BPI for this indication. "I'm hopeful that the FDA will reconsider its decision. The evidence is clear that BPI will reduce death and loss of limbs," Giroir said."" This data was as I said disputed by the FDA. The FDA reply to such claims is found in the correspondence area of the Lancet and is available on line. If you post 2 year old news, my eyes will glance at it and my mind will think inappropriate things and my fingers post something on their own. Today spot gold is up $4 per oz!! No FDA to decide if it should be or not.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next